Molecular Cancer Therapeutics

Published by: American Association for Cancer Research  

People

  1. Heller
    Heller
  2. Scher
    Scher
  3. Schultz
    Schultz
  4. Schwartz
    Schwartz
  5. Aras
    Aras
  6. Blasberg
    Blasberg
  7. Calder
    Calder
  8. Carver
    Carver
  9. Chatila
    Chatila
  10. Chen
    Chen

Groups

  1. Epidemiology and Biostatistics (12)
  2. Sloan Kettering Institute Postdocs (9)
  3. Biostatistics Service (7)
  4. Department of Medicine (7)
  5. Solid Tumor Oncology Division (7)
  6. GSK Faculty (6)
  7. Genitourinary Oncology Service (5)
  8. Surgery (4)
  9. Body Imaging Service (3)
  10. Center for Hematologic Malignancies (3)
Search Within
  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (9)
  2. Meeting Abstract (3)
Groups
  1. Epidemiology and Biostatistics (12)
  2. Sloan Kettering Institute Postdocs (9)
  3. Biostatistics Service (7)
  4. Department of Medicine (7)
  5. Solid Tumor Oncology Division (7)
  6. GSK Faculty (6)

More Groups

People
  1. Glenn Heller (3)
  2. Howard Scher (3)
  3. Audrey Mauguen (2)
  4. Gouri Nanjangud (2)
  5. Lawrence Schwartz (2)
  6. Nestor Rosales (2)

More People

Years
  1. 2022 (4)
  2. 2021 (2)
  3. 2019 (1)
  4. 2015 (2)
  5. 2010 (1)
  6. 2007 (2)
Publishers
  1. American Association for Cancer Research (12)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Inhibition of NF-κB DNA binding suppresses myeloma growth via intracellular redox and tumor microenvironment modulation
    Journal Article

    Bariana, M.; Cassella, E.; Rateshwar, J.; Ouk, S.; Liou, H. C.; Heller, C.; Colorado, I.; Feinman, R.; Makhdoom, A.; Siegel, D. S.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Optimal strategy and benefit of pulsed therapy depend on tumor heterogeneity and aggressiveness at time of treatment initiation
    Journal Article

    Mathur, D.; Taylor, B. P.; Chatila, W. K.; Scher, H. I.; Schultz, N.; Razavi, P.; Xavier, J. B.
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Dual fluorescence isogenic synthetic lethal kinase screen and high-content secondary screening for MUC16/CA125-selective agents
    Journal Article

    Rao, T. D.; Xu, M.; Eng, S.; Yang, G.; Manson, R.; Rosales, N.; Kumar, R.; Veillard, I. E.; Zhou, Q.; Iasonos, A.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Targeting the mTOR pathway in hurthle cell carcinoma results in potent antitumor activity
    Journal Article

    Dong, Y.; Gong, Y.; Kuo, F.; Makarov, V.; Reznik, E.; Nanjangud, G. J.; Aras, O.; Zhao, H.; Qu, R.; Fagin, J. A.; more...
    Molecular Cancer Therapeutics (2022)

    Fulltext@MSK | Save
  • Translational strategies for repotrectinib in neuroblastoma
    Journal Article

    O'Donohue, T. J.; Ibáñez, G.; Coutinho, D. F.; Mauguen, A.; Siddiquee, A.; Rosales, N.; Calder, P.; Ndengu, A.; You, D.; Long, M.; more...
    Molecular Cancer Therapeutics (2021)

    Fulltext@MSK | Save
  • Phase 0 clinical trial of everolimus in patients with vestibular schwannoma or meningioma
    Journal Article

    Karajannis, M. A.; Mauguen, A.; Maloku, E.; Xu, Q.; Dunbar, E. M.; Plotkin, S. R.; Yaffee, A.; Wang, S.; Roland, J. T.; Sen, C.; more...
    Molecular Cancer Therapeutics (2021)

    Fulltext@MSK | Save
  • Targeting nucleotide excision repair defects in cancer
    Meeting Abstract

    Topka, S.; Steinsnyder, Z.; Tkachuk, K.; Ravichandran, V.; Madsen, M. W.; Furberg-Barnes, H.; Iyer, G.; De Stanchina, E.; Joseph, V.; Offit, K.
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • Enhanced GAB2 expression is associated with improved survival in high-grade serous ovarian cancer and sensitivity to PI3K inhibition
    Journal Article

    Davis, S. J.; Sheppard, K. E.; Anglesio, M. S.; George, J.; Traficante, N.; Fereday, S.; Intermaggio, M. P.; Menon, U.; Gentry-Maharaj, A.; Lubinski, J.; more...
    Molecular Cancer Therapeutics (2015)

    Fulltext@MSK | Save
  • Identifying actionable targets through integrative analyses of GEM model and human prostate cancer genomic profiling
    Journal Article

    Wanjala, J.; Taylor, B. S.; Chapinski, C.; Hieronymus, H.; Wongvipat, J.; Chen, Y.; Nanjangud, G. J.; Schultz, N.; Xie, Y.; Liu, S.; more...
    Molecular Cancer Therapeutics (2015)

    Fulltext@MSK | Save
  • Genetically engineered oncolytic newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma
    Journal Article

    Silberhumer, G. R.; Brader, P.; Wong, J.; Serganova, I. S.; Gonen, M.; González, S. J.; Blasberg, R.; Zamarin, D.; Fong, Y.
    Molecular Cancer Therapeutics (2010)

    Fulltext@MSK | Save

    • Molecular Cancer Therapeutics – authorized name for:

    Name ISSN / ISBN Publisher
    Molecular Cancer Therapeutics 15388514 American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 15388514 American Association for Cancer Research
    Molecular cancer therapeutics 15388514 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 Unknown
    Molecular Cancer Therapeutics 15357163 The Authors the American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 1535-7163 American Association for Cancer Research
    Molecular Cancer Therapeutics 15357163 Unknown
    Molecular Cancer Therapeutics 15357163 American Association for Cancer Research